- Browse by Topic
- 13 Reasons Why
- ABA
- Abstinence
- Acamprosate
- Addiction
- Addiction Treatment
- Addyi
- Adhansia
- Adhansia XR
- ADHD
- ADHD Attention Deficit Hyperactivity Disorder
- ADHD Rating Scale-5
- ADHD-RS-5
- Adherence
- Adjunct treatment
- adolescents
- Aducanumab
- Aduhelm
- Adult ADHD
- Adverse Childhood Experiences (ACES)
- adverse events
- affective disorders
- Affordable Care Act (ACA)
- aggression
- Agitation
- Aid to capacity evaluation (ACE)
- AIMS test (Assessment of Involuntary Movement)
- air pollution
- Akathisia
- Alcohol
- alcohol abuse
- alcohol dependence
- Alcohol Poisoning
- Alcohol related liver disease
- Alcohol Use
- Alcohol use disorder
- alcohol- associated liver disease
- Alcoholism
- Alpha Agonists
- Altered Mental Status (AMS)
- Alternative treatments
- Alzheimers
- Amantadine
- amino acids
- amphetamine
- Amphetamines
- anabolic steroids
- Andro
- Androstenedione
- Anorexia
- Anorexia Nervosa
- Anti-NMDA Receptor Encephalitis
- Antibiotic
- Anticholinergic burden scale
- Anticholinergics
- anticonvulsants
- Antidepressant
- Antidepressant Augmentation
- Antidepressants
- antihistamines
- Antipsychotic
- Antipsychotics
- Anxiety
- Anxiety Disorder
- anxiety disorders
- APA CE Post-Test
- Apathy
- Applied Behavioral Analysis
- Aptensio
- ARFID
- Aripiprazole
- ArModafinil
- Asenapine
- Ashton manual
- Assault
- Assent
- Assessment
- assessments
- asthma
- atamoxetine
- Athletic performance
- Ativan Challenge Test
- Atomoxetine
- Atomoxetine (ATX)
- Atrophy
- Atropine
- attention
- Attention Deficit Hyperactivity Disorder
- Atypical Antipsychotics
- Austedo
- Autism
- Autism Spectrum Disorder
- Autism Spectrum Disorder
- Autism Spectrum Disorder autism spectrum disorder
- Avoidant Restrictive Food Intake Disorder
- Beers criteria
- Behavior therapy
- Behavioral addiction
- Behavioral therapy
- Behavioral treatment
- Belsomra
- Benzodiazepine
- Benzodiazepines
- Benzphetamine
- Beta-blockers
- Billing
- Bipolar Depression
- Bipolar Disorder
- Bipolar II
- birth defects
- Black youth
- Bleeding
- Board Certification
- body mass index BMI
- body positivity
- Borderline Personality Disorder
- Boredom
- BPD
- BPSD (behavioral and psychological symptoms of dementia)
- Brain Devices
- Breastfeeding
- Brexpiprazole
- Brief psychotherapy
- brief pulse
- Brief Strategic Family Therapy (BFST)
- Bulimia Nervosa
- Bullying
- Bumetanide
- Buprenorphine
- Buprenorphine Induction
- Bupropion
- Bush-Francis Scale
- Buspirone
- C-Reactive Protein
- Caffeine
- CAM Treatments
- Cancer
- Cannabidiol
- Cannabis
- cannabis products
- cannabis use disorder
- cannabis withdrawal
- Capacity
- Caplyta
- Carbamazepine
- Cardiovascular
- Cariprazine
- Catatonia
- CATIE
- CBT
- CBTi
- Central Alpha Agonists
- CGI
- Chantix
- child abuse
- Child and adolescent
- Child Psychiatry
- Child Psychiatry
- childcare
- children
- children and adolescents
- Chlorpromazine
- Chokroverty
- Chromosomal Microarray
- circadian system
- Citalopram
- Clinical Global Impressions
- Clinical practice
- Clinical Practice Guidelines
- clonidine
- Clozapine
- CME Post-Test
- co-morbidities
- Co-occurring disorders
- Cocaine
- Cognition
- Cognitive Behavioral Therapy
- Cognitive Behavioral Therapy for Insomnia
- Cognitive Behavioral Therapy for Insomnia (CBTi)
- Cognitive Decline
- Cognitive functioning
- cognitive impact
- Cognitive impairment
- cognitive processing therapy
- Cognitive Rehabilitation Therapy (CRT)
- Collaboration
- Collaborative care
- Collateral data
- college mental health
- Combination treatment
- Combined Pharmacotherapy
- Commitment
- community trauma
- Comorbidity
- complementary medicine
- Complementary treatments
- Complimentary Medicine
- Complimentary treatments
- compulsions
- Computer addiction
- Computers in Psychiatric Practice
- Conduct Disorder
- Confidentiality
- Confusion
- Confusion Assessment Method (CAM)
- Connect
- Connection
- Connections
- Consensual
- Consent
- consult-liaison
- Contagion
- Contempla
- contingency management
- contraception
- contraceptive services
- control group
- Coronavirus
- Cosmetic pharmacology
- Countertransference
- court hearings
- COVID-19
- COVID19
- craving
- creatine
- creatine monohydrate
- Creativity
- Crime
- Criminal behavior
- Crisis intervention
- Crocus Sativus
- CRP
- CT
- Cultural Competence
- Culture
- custody agreement
- Cymbalta
- CYP2C19
- CYP2D6
- DASH diet
- DaT Scan
- Dayvigo
- De-escalation
- Debriefing
- Decisional Capacity
- Deep brain stimulation (DBS)
- Degarelix
- Deliberate foreign body ingestion
- Delirium
- Delusional Disorder
- Dementia
- Deplin
- Deprescribing
- Depression
- Depressive Disorder
- designer drugs
- Detoxification
- Deutetrabenazine
- Developmental Relationship Based Intervention
- DFBI
- Diabetes
- diabetes insipidus
- Diagnosis
- Diagnostic Testing
- Dialectical Behavioral Therapy
- diet
- Dietary Approaches to Stop Hypertension (DASH)
- Diethylpropion
- differential diagnosis
- Diphenhydramine
- Disaster
- Discrepancies
- Disinhibition
- Disorganization
- Disparities
- dispensary
- Dispositional capacity
- Disruptive Mood Dysregulation Disorder (DMDD)
- Disulfiram
- Divalproex
- Diversity
- Divorce
- DMDD
- Dopamine
- Dosage Timing
- Dose Response
- Dosing
- double blind
- Double blind trial
- DRBI
- Drooling
- Droperidol
- drug misuse
- Drug-assisted psychotherapy
- DSM
- Dual diagnosis
- Duloxetine
- duty to protect
- duty to warn
- Dyanaval
- Dyslexia
- Dysregulation
- E-Cigarettes
- Eating Disorders
- eating restriction
- eCigarettes
- ECT
- effect size
- Effexor
- efficacy
- EHR
- Electroconvulsive therapy
- Electronic Health Records
- electronic use
- Emergency
- Emergency Department
- emergent suicidality
- emotion dysregulation
- Emotional dysregulation
- EMPOWER trial
- Encephalitis
- End of Life Care
- endocrinological side effects
- Engagement
- Equine Assisted Psychotherapy
- Equine therapy
- Escitalopram
- Esketamine
- Estrogen
- Eszopiclone
- eTNS
- Evekeo
- excessive exercise
- Exercise
- Existing marijuana
- expressed emotion
- extended dosing
- extended-release
- Eye movement desensitization and reprocessing
- Fall risk
- Falls
- Family Separation
- Fast-acting
- fat shaming
- FDA
- FDA Warnings
- Female hypoactive sexual desire disorder
- Female Issues in Psychiatry
- fentanyl
- fetal effects
- First Generation Antipsychotics (FGAs)
- Flu Shot
- fluid restriction
- Fluoxetine
- fMRi
- Folate
- Folic Acid
- Fragile X
- Free Articles
- Frontotemporal dementia
- gabapentin
- GAD
- gambling
- GAMC
- Gastroenterology
- GDD
- Gender
- Gender & Sexuality
- Gender Affirming Medical Care
- Gender Diverse
- Gender Dysphoria
- Gender Dysphoric Disorder
- Gender Identity
- Generalized Anxiety Disorder
- Generics
- GeneSight
- Genetic Testing
- Genetics and Psychiatry
- Geriatric
- Geriatric Depression Scale (GDS)
- Geriatric Psychiatry
- Geriatrics
- Ginkgo
- GLP-1 Agonists
- Good Psychiatric Management
- Guanfacine
- Hair loss
- Haloperidol
- Harm reduction
- Head Trauma
- Health Apps
- Healthy aging
- Hearing loss
- Heart rate
- Hemorrhagic
- Hepatitis
- Heroin
- Higher-calorie refeeding
- HIPAA
- Histamine
- HIV
- Hormone Replacement Therapy
- hospital culture
- Hospital policy
- HRT
- huffing
- hydroxymethyl butyrate (HMB)
- Hydroxyzine
- hyperlipidemia
- hypersalivation
- hypersexual behaviors
- hypertension
- Hypnotics
- Hypomania
- Hyponatremia
- hypothyroidism
- IDEA
- Imaging
- Immune System
- Incarceration
- Inclusion
- Inclusion strategies
- Independent Educational Plan (IEP)
- induction
- infant
- Inflammation
- Influenza vaccination
- Ingrezza
- Inhalants
- Innovations
- Inpatient Psychiatry
- inquiry
- Insomnia
- Insulin resistance
- Insurance
- intermittent fasting
- Internet
- internet-based treatment
- interpersonal stressors
- Interpreter
- Intervention
- Intra-cerebral hemorrhage
- Intra-nasal
- involuntary civil commitment
- Irritability
- IV immunoglobulin therapy (IVIG)
- Jornay PM
- Keppra
- Ketamine
- l-methylfolate
- Laboratory Testing in Psychiatry
- lactation
- Lamictal
- Lamotrigine
- Language
- LATE
- Lavender
- Learning & Developmental Disabilities
- Least Restrictive Environment
- Legal issues
- Lemborexant
- Levetiracetam
- Lewy Body Dementia
- LGBT
- LGBTQ+
- Life coaching
- Life expectancy
- Light and Dark Therapy
- Light therapy
- Lightbox
- Liraglutide
- Literacy
- Lithium
- long-acting buprenorphine
- Longevity
- lorazepam taper
- Low calorie refeeding
- Low libido
- low sodium
- Lumateperone
- Lurasidone
- Lyrica
- magnetic seizure therapy (MST)
- maintenance ECT
- Malingering
- Malnourishment
- Management
- Mania on Antidepressants
- MAOIs
- Marijuana
- MDMA
- Media
- Medical Comorbidities
- medical comorbidity
- medical conditions
- Medical incapacity hold
- Medication
- Medication adherence
- medication capacity hold
- Medication for Opioid Use Disorder
- Medication for Opioid Use Disorder (MOUD)
- medication of opioid use disorder (MOUD)
- medications
- medicinal cannabis
- Melatonin
- Memantine
- memory loss
- Mental Health
- Meta-analysis
- Metabolic syndrome
- Metformin
- Methadone
- Methamphetamines
- methylfolate
- methylphenidate
- Microglia
- Micronutrients
- mild cognitive impairment
- Mind-Gut Connection
- mindful eating
- Mindfulness
- Minocycline
- Minority
- Mirtazapine
- Mixed Features
- MMSE
- MOCA
- Modafinil
- Mood
- mood disorders
- Mood stabilizer
- Mood Stabilizers
- Mortality
- Motivational Interviewing
- MRI
- MTA
- MTHFR
- muscle dysmorphia
- Mydayis
- Naloxone
- Naltrexone
- Narcolepsy
- Natural Medications
- natural treatments
- Naturalistic Developmental-Behavioral Intervention
- NDBI
- Negative Symptoms
- Negative symptoms of schizophrenia
- Netflix
- neuroleptic malignant syndrome
- Neurology
- Neuromodulation
- Neuropsychological testing
- Neuroscience in Psychiatry
- Neurotoxicity
- New York
- newborn
- News of Note
- nicotine
- Nightmares
- NMDA
- NNH
- NNT
- Nomogram
- Non-pharmacologic
- Non-suicidal self-injury
- Norepinephrine
- Nortriptyline
- Novel drug
- Novel Medications
- Nuedexta
- null hypothesis
- number needed to harm
- number needed to treat
- Nuplazid
- Nurses
- Nutrition
- Nuvigil
- Obesity
- observational study
- obsessions
- Obsessive Compulsive Disorder
- Obsessive compulsive disorder/OCD
- OCD
- olanzapine
- Omega-3
- Online Learning
- online therapy
- Open Label
- open label trial
- Opioid antagonist
- Opioid epidemic
- Opioid Use Disorder
- Opioids
- oppositional behavior
- Oral Contraceptives
- Orexin
- Orthostasis
- Osmolality
- Osteporosis
- OUD
- Outcome tracking
- Outcomes
- Outpatient
- Over the counter
- Over the counter medication
- Overdiagnosis
- Overdose
- Oxcarbazepine
- p-value
- Pain
- pandemic
- Panic Disorder
- Parent Training
- Parenting Strategies
- Parents
- Parkinson’s
- Parkinson’s Disease
- Paroxetine
- Particulate matter
- Patch
- Patient relationship
- PCL-5
- pediatric
- Pediatric Acute Onset Neuropsychiatric Syndrome (PANS)
- Pediatric Autoimmune Neurologic Disorder Associated with Streptococcus (PANDAS)
- Pedophilic Disorder
- Performance Enhancing Substances
- perinatal
- Perseveration
- Perseverative Behavior
- Personality Disorders
- PET Scan
- Pharmaceutical Industry
- Pharmacogenomics
- Pharmacology
- Pharmacology Tips
- Pharmacotherapy
- Pharmacy
- Phendimetrazine
- Phentermine
- phonemic awareness
- Phonics
- Physician assisted suicide
- Pica
- PICOT
- Pimozide
- Pitolisant
- Podcast
- polypharmacy
- post traumatic stress disorder
- post-exposure prophylaxis
- Post-hoc Analysis ADHD Rating Scale-5
- Post-menopausal
- Post-stroke depression
- Posterior Probability
- Postpartum Depression
- postpartum mood
- Potency
- Practice management
- Practice Tools and Tips
- Practice Tools and Tips
- Pramipexole
- Prazosin
- Pregabalin
- Pregnancy
- pregnancy testing
- Prepubescent children
- prescribing patterns
- Prescription costs
- prevalence
- Prevention
- Primary care
- primary outcome
- Prison
- Privacy
- Prodrome
- Prolactin
- Prolonged exposure
- Promethazine
- Promotoras
- Pronouns
- Provigil
- Prozac
- pseudobulbar affect
- Psilocybin
- Psychedelics
- psychiatric emergencies
- Psychiatric interviewing
- Psychoanalysis
- Psychodynamic therapy
- Psychological First Aide
- Psychopharm Myths
- Psychopharmacology
- Psychopharmacology Tips
- Psychosis
- Psychotherapy
- Psychotherapy
- Psychotic Agitation
- Psychotic Depression
- psychotic disorders
- Psychotropic medication
- PTSD
- Public health
- Qelbree
- Quality of care
- quality of life
- Quetiapine
- Quillivant
- Race
- Raloxifene
- Randomized controlled trial
- randomized discontinuation design
- rapid naming
- Rapid-acting
- RCT
- Reading
- Reading disorder
- Reading Disorders
- Reading remediation
- recovery time
- Red Cross
- Refeeding syndrome
- Registered Articles
- Relationships
- Remediation
- Repetitive Behavior
- Repetitive behaviors
- replication
- reporting requirements
- Research
- Research Update
- Research Updates
- Respectful Care
- restraints
- restrictive dieting
- retarded vs excited catatonia
- retention
- Retirement
- retrograde amnesia
- Riluzole
- Risk
- Risk Management
- Risk of Addiction
- Risperidione
- Risperidone
- Ritalin
- rTMS
- Safe Consumption Site
- safety
- Safety Planning
- Saffron
- SAINT protocol
- SAMe
- Samidorphan
- Saphris
- Schizoaffective disorder
- Schizophrenia
- School Phobia
- School Refusal
- screening
- ScreeninGeg
- Seasonal Affective Disorder
- seclusion
- Second Generation Antipsychotics (SGAs)
- secondary outcome
- Secuado
- Self-injury
- Self-Regulation
- Semaglutide
- Separation
- Separation Anxiety
- SERM (Selective Estrogen Receptor Modulator)
- Serotonin
- Serotonin Norepinephine Reuptake Inhibitors
- Serotonin Specific Reuptake Inhibitors
- Serotonin Specific Reuptake Inhibitors (SSRIs)
- Sertraline
- Sex offenders
- Sex Therapy
- Sexual Abuse
- Sexual Dysfunction
- sexual intercourse
- Sexual Side Effects
- sexually transmitted diseases
- SIADH
- Side Effects
- Silexan
- Skype
- Sleep
- Sleep Apnea
- Sleep Disorders
- Sleep Onset Insomnia
- SLUMS
- Smoking Cessation
- Smoking Cessation Agents
- smoking cessations
- SNRIs
- Social Anxiety
- Social Anxiety Disorder
- social cohesion
- sodium supplementation
- Somnambulism
- Special populations
- Specific Phobia
- SSRIs
- statistical significance
- Statutes
- Stereotypical Behavior
- steroids
- STI screening
- Stigma
- stimulant
- Stimulant Medications
- Stimulant treatment
- Stimulant use disorder
- Stimulants
- Stroke
- structured literacy
- Suboxone
- Substance Abuse
- Substance Abuse
- Substance Use
- Substance Use Disorder
- Substance use disorders
- Suicidality
- Suicide
- Sundowning
- Supplementation
- Supplements
- Surrogate decision-maker
- Suvorexant
- Swallowing
- Symptom Assessment
- Symptom Management
- Systematic review
- Tags
- Tantrums
- taper
- Tarasoff
- Tardive dyskinesia
- Technology
- Teen
- teens
- Telehealth
- Telemed
- Telemedicine
- Telepsychiatry
- test cme quiz
- testifying
- Tetrabenazine
- TFCBT
- TGD
- Therapy during medication appointment
- Therapy with Med Management
- Theta burst stimulation
- tics
- TMS
- Tobacco
- tobacco research
- Tobacco use disorder
- Top 10 Podcasts of 2021
- Topiramate
- Toxic Stress
- Transcranial direct current stimulation (TDCS)
- Transcranial Magnetic Stimulation
- Transdermal
- Transgender
- Translator
- transplant surgery
- Trauma
- Trauma Informed Care
- Trauma-focused psychotherapy
- Traumatic Brain Injury (TBI)
- Trazodone
- treatment
- treatment efficacy
- treatment pediatric
- Treatment planning
- Treatment-Resistant Depression
- Trigeminal Nerve Stimulation
- Trintellix
- unblinded
- Understanding Psychiatric Research
- unilateral vs bilateral
- urinary difficulties
- urinary tract infections
- urine toxicology
- UTI
- Vagus nerve stimulation (VNS)
- Valbenazine
- Valproate
- Vaping
- Varenicline
- Venlafaxine
- verbal de-escalation
- videogaming addiction
- Viloxazine
- Violence
- Vitamin B12
- Vitamin B6
- Vitamin D
- Vitamin E
- VMAT2 Inhibitors
- Vortioxetine
- Vyleesi
- Vyvanse
- Waist circumference
- Wakix
- water intoxication
- water restriction
- Weed
- Weight gain
- Weight Loss Medications
- Weiss Functional Impairment Rating Scale-Parent (WFIRS-P)
- Wellbutrin
- whey protein powders
- White matter hyperintensities
- Whole Genome Sequencing
- Wilderness Therapy Programs
- Withdrawal
- women
- Women's Issues in Psychiatry
- Women’s Issues in Psychiatry
- Working With Families
- workplace
- Xenazine
- Youth
- Z-drugs
- Zenzedi and ProCentra
- Ziprasidone
MTHFR
Expert Q&A
Pharmacogenetics: Not Quite Ready for Prime Time?
Topics: Chromosomal Microarray | CYP2C19 | CYP2D6 | Fragile X | Genetic Testing | MTHFR | Pharmacogenomics | Whole Genome Sequencing
CCPR: Welcome, Dr. Besterman. Please tell us who you are and where you work. Dr. Besterman: I’m an adult and child & adolescent psychiatrist at the Rady Children’s Hospital inpatient child and adolescent unit in San Diego, and I’m a clinical investigator at the Rady Children’s Institute for Genomic Medicine studying psychiatric genetics.
Read More